Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erman Akkus

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Gastrointestinal Cancer|February 5, 2025
Low-Density Lipoprotein (LDL) is Associated with Earlier Progression in Synchronous Metastatic Colorectal Cancer Treated without Curative IntentErman Akkus, Nejat Emre Öksüz, Güngör Utkan
Critical Reviews in Oncology/Hematology|April 30, 2024
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysisSati Coskun Yazgan, Erman Akkus, Emre Yekeduz, et al.
Expert Review of Hematology|September 25, 2025
Somatic variants and frequencies of familial myeloma germline predisposition genes among patients within the CoMMpass datasetErman Akkus, Timur Tuncalı, Hasan Yalim Akin, et al.
Targeted Oncology|April 13, 2025
Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysisErman Akkus, Hatime Arzu Yasar, Lorenza Rimassa, et al.
Future Oncology (London, England)|February 25, 2025
Hepatic steatosis development as a long-term complication among testicular germ cell tumor survivorsErman Akkus, Ali Devrim Karaosmanoğlu, Başak Gülpınar, et al.
Journal of Cancer|February 3, 2025
Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon CancerErman Akkus, Mehmet Kayaalp, Beliz Bahar Karaoğlan, et al.
Cardiovascular Diabetology|November 19, 2018
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome ratsAysegul Durak, Yusuf Olgar, Sinan Degirmenci, et al.
Clinical and Experimental Pharmacology & Physiology|September 14, 2021
Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca<sup>2+</sup> abnormalities and mitochondrial dysfunctionAysegul Durak, Erman Akkus, Asena Gokcay Canpolat, et al.
International Journal of Cancer|January 31, 2025
Stage-specific characterization of "early-onset colorectal cancer": Localized and synchronous metastatic diseaseErman Akkus, Beliz Bahar Karaoğlan, Mehmet Kayaalp, et al.
American Journal of Surgery|February 27, 2025
Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancerErman Akkus, Beliz Bahar Karaoğlan, Barış Akçadağ, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Gastrointestinal Cancer|February 5, 2025
Low-Density Lipoprotein (LDL) is Associated with Earlier Progression in Synchronous Metastatic Colorectal Cancer Treated without Curative IntentErman Akkus, Nejat Emre Öksüz, Güngör Utkan
Critical Reviews in Oncology/Hematology|April 30, 2024
Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysisSati Coskun Yazgan, Erman Akkus, Emre Yekeduz, et al.
Expert Review of Hematology|September 25, 2025
Somatic variants and frequencies of familial myeloma germline predisposition genes among patients within the CoMMpass datasetErman Akkus, Timur Tuncalı, Hasan Yalim Akin, et al.
Targeted Oncology|April 13, 2025
Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysisErman Akkus, Hatime Arzu Yasar, Lorenza Rimassa, et al.
Future Oncology (London, England)|February 25, 2025
Hepatic steatosis development as a long-term complication among testicular germ cell tumor survivorsErman Akkus, Ali Devrim Karaosmanoğlu, Başak Gülpınar, et al.
Journal of Cancer|February 3, 2025
Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon CancerErman Akkus, Mehmet Kayaalp, Beliz Bahar Karaoğlan, et al.
Cardiovascular Diabetology|November 19, 2018
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome ratsAysegul Durak, Yusuf Olgar, Sinan Degirmenci, et al.
Clinical and Experimental Pharmacology & Physiology|September 14, 2021
Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca<sup>2+</sup> abnormalities and mitochondrial dysfunctionAysegul Durak, Erman Akkus, Asena Gokcay Canpolat, et al.
International Journal of Cancer|January 31, 2025
Stage-specific characterization of "early-onset colorectal cancer": Localized and synchronous metastatic diseaseErman Akkus, Beliz Bahar Karaoğlan, Mehmet Kayaalp, et al.
American Journal of Surgery|February 27, 2025
Combined preoperative and post-adjuvant-chemotherapy carcinoembryonic antigen levels are prognostic for early recurrence and survival in stage III colon cancerErman Akkus, Beliz Bahar Karaoğlan, Barış Akçadağ, et al.
Pageof 4